Skip to content
CED Clinic
Contact Us Book Consultation GLP-1 Care
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
  • Facebook
  • X
  • Email
  • Instagram
  • YouTube
  • Substack
  • Dr Caplan’s Book
CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
Subscribe
Close

Search

Exclusive
water-dispersible cannabis drops finished recipe styled as the emotional anchor with warm editorial food photography
August 14, 2026
How to Make Water-Dispersible Cannabis Drops
cannabis spiced pear shrub spritzer finished recipe styled as the emotional anchor with warm editorial food photography
August 14, 2026
Cannabis Spiced Pear Shrub Spritzer Recipe
Government building in Georgia representing the state medical cannabis delivery rulemaking process
August 14, 2026
Georgia Proposes Home Delivery for Medical Cannabis Patients
Nabiximols vs Cannabis Decoction MS Spasticity | nabiximols cannabis decoction MS spasticity study
August 14, 2026
Nabiximols vs. Cannabis Decoction for MS Spasticity: What a New Formulation Comparison Study Found
Massachusetts Cannabis Regulators Reveal THC Potency Audit Results
August 14, 2026
Massachusetts Cannabis Regulators Reveal THC Potency Audit Results
Massachusetts cannabis regulators catch mislabeled flower in THC audit
August 14, 2026
Massachusetts cannabis regulators catch mislabeled flower in THC audit
Cbd Gummies Good For Inflammation: A Data Driven Look At Efficacy, Quality, And Reality ...
August 14, 2026
Cbd Gummies Good For Inflammation: A Data Driven Look At Efficacy, Quality, And Reality …
How to Choose the Right Edible Dosage
August 14, 2026
How to Choose the Right Edible Dosage
'Scromiting' Can Happen With Frequent Cannabis Use. What Are the Symptoms?
August 14, 2026
‘Scromiting’ Can Happen With Frequent Cannabis Use. What Are the Symptoms?
ced unsplash KJbK6WqpGd4
August 14, 2026
Massachusetts THC Potency Audit Flags 13 Cannabis Flower Products
US: Georgia medical cannabis registry surges 22% after law eases access
August 14, 2026
US: Georgia medical cannabis registry surges 22% after law eases access
Canada Invests $24 Million To Study Impact Of Cannabis On Brain Health
August 14, 2026
Canada Invests $24 Million To Study Impact Of Cannabis On Brain Health
Contrary To Expectations, Study Shows Cannabis Linked To Fewer Ectopic Heartbeats
August 14, 2026
Contrary To Expectations, Study Shows Cannabis Linked To Fewer Ectopic Heartbeats
Dr. Mitch: Federal government invests $24 million for cannabis and brain health research
August 14, 2026
Dr. Mitch: Federal government invests $24 million for cannabis and brain health research
Could Truly Water-Soluble Cannabidiol Improve Oral Dosing?
August 14, 2026
Could Truly Water-Soluble Cannabidiol Improve Oral Dosing?
Oral Semaglutide for Alcohol Use Disorder Trial | oral semaglutide alcohol use disorder trial
August 14, 2026
Oral Semaglutide for Alcohol Use Disorder: What a New Randomized Trial Found
cannabis eggplant caponata spread finished recipe styled as the emotional anchor with warm editorial food photography
August 14, 2026
Cannabis Eggplant Caponata Spread Recipe
Medical Cannabis Provides Relief for Endometriosis Symptoms
August 14, 2026
Medical Cannabis Provides Relief for Endometriosis Symptoms
UW awarded $2.4M in new Canadian cannabis research effort
August 14, 2026
UW awarded $2.4M in new Canadian cannabis research effort
Suspect accused of stabbing man with machete in Leominster
August 14, 2026
Suspect accused of stabbing man with machete in Leominster
A six-hour time series of the acute effects of ingested cannabis intoxication on a battery of ...
August 14, 2026
A six-hour time series of the acute effects of ingested cannabis intoxication on a battery of …
For decades, runner's high was blamed on endorphins, even though circulating ...
August 14, 2026
For decades, runner’s high was blamed on endorphins, even though circulating …
Oral VCT220 GLP-1 Obesity Phase II Trial | oral VCT220 GLP-1 obesity trial
August 14, 2026
Oral VCT220 Phase II Trial: GLP-1 Receptor Agonist for Obesity
cannabis crispy edamame snack finished recipe styled as the emotional anchor with warm editorial food photography
August 13, 2026
Cannabis Crispy Edamame Snack Recipe
Oral CBG Safety Study | cannabigerol CBG safety study
August 13, 2026
Oral Cannabigerol (CBG): What a New Human Safety Study Actually Found
2-AG
August 13, 2026
2-AG
Researchers Try to Tie Cannabis to Irregular Heartbeats, Opposite Turns Out True
August 13, 2026
Researchers Try to Tie Cannabis to Irregular Heartbeats, Opposite Turns Out True
Over 300 Important Cannabis Studies Published in 2026
August 13, 2026
Over 300 Important Cannabis Studies Published in 2026
Medical Marijuana Improves Pain, Sleep And Anxiety In Women With Endometriosis While ...
August 13, 2026
Medical Marijuana Improves Pain, Sleep And Anxiety In Women With Endometriosis While …
Certain cannabis-based therapies may help relieve spasticity in MS
August 13, 2026
Certain cannabis-based therapies may help relieve spasticity in MS
Illinois State Capitol dome in Springfield, representing the state's medical cannabis dispensary licensing process
August 13, 2026
Illinois Posts New Path for Adult-Use Dispensaries to Serve Medical Cannabis Patients
Home/Cannabis Science/Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Shows
ced pexels 7231457
Cannabis Science

Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Shows

By Benjamin Caplan, MD
9 Min Read
Comments Off on Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Shows
CED Clinical Relevance
#58
Contextually Relevant
This paper is not cannabis-specific, but it matters clinically because trauma burden strongly shapes substance use risk, treatment engagement, and long-term psychiatric care.
? Clinical Insight | CED Clinic
A study like this supports trauma-informed addiction care, not simplistic blame narratives. It raises an important clinical question, namely how often substance treatment settings are seeing the downstream effects of childhood adversity without formally measuring them.
Evidence Watch
Childhood Trauma
Addiction Psychiatry
Kenya
Trauma-Informed Care
Audience Clinicians, public health readers, policymakers, patients, families, and caregivers
Primary Topic Adverse childhood experiences and substance use disorders
Source Read the full article

Table of Contents

  • Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Actually Shows
    • Frequently Asked Questions
      • 1. What kind of study was this?
      • 2. Did the study prove that childhood trauma causes addiction?
      • 3. How common were adverse childhood experiences in this sample?
      • 4. Which substances were most commonly used?
      • 5. Which childhood adversities were linked to current substance use?
      • 6. Why should clinicians care about this paper?
      • 7. Can these results be generalized to everyone with addiction?
      • 8. Were there any important limitations beyond sample size?
      • 9. Does this paper support routine ACE screening in substance treatment settings?
      • 10. What is the most careful one-sentence takeaway?
  • Newsletter Signup Form
      • Read next
      • Related

Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Actually Shows

Talk to Dr. Caplan

Want to apply this research to your own care?

30,000+ patients treated. Appointments in Massachusetts and via telemedicine.

Book a consultation →GLP-1 + cannabis program
BC

Dr. Benjamin Caplan, MD

Board-certified Family Medicine

20+ years in cannabis medicine. CMO, CED Clinic. Author, Penguin Random House. Principal Investigator in multiple studies.

Full bio →

Related reading

  • Conditions A–Z →
  • Cannabis & anxiety →
  • Cannabis & sleep →
  • Cannabinoid profiles →

Wherever you are

Dr. Caplan offers consultations for complex conditions and wellness needs. Patients from across the US and internationally are welcome.

Book a consultation →

This cross-sectional study of adults receiving inpatient treatment at Kenya’s national referral psychiatric hospital asks an important question: how common are adverse childhood experiences among people already in treatment for addiction, and which specific adversities are associated with current substance problems? The paper adds useful clinical context, especially for trauma-informed care, but because of its design it should be read as an association study, not a proof-of-causation study.

What This Study Teaches Us

This paper is a descriptive cross-sectional study, which means it can describe prevalence and associations but cannot establish temporal direction or causality. In this inpatient Kenyan sample, adverse childhood experiences and substance use disorders appeared tightly linked: 92.5% of participants reported at least one ACE, and several childhood adversities were associated with higher odds of current tobacco, cannabis, or sedative use. The study is most useful as a reminder that trauma histories are common in addiction treatment settings and may shape clinical presentation. Its biggest limitation is that all exposure data were retrospective self-report, collected in a small convenience sample from one referral hospital.

Why This Matters

For the public: People often talk about addiction as though it begins with bad choices in adulthood. This paper pushes back on that oversimplification by showing how frequently difficult childhood environments appear in the histories of adults receiving treatment for substance use disorders.

For providers: This study supports routine curiosity about trauma, family dysfunction, neglect, and abuse in addiction settings. It does not justify assuming every substance problem is trauma-driven, but it does suggest that trauma-informed interviewing and treatment planning are clinically sensible.

For systems and policymakers: If childhood adversity is common in people later presenting with addiction, then prevention efforts cannot be limited to drug education alone. Early family support, violence prevention, child protection, and access to mental health services may all matter upstream, even though this paper alone cannot quantify the downstream causal effect of any one intervention.

Study Snapshot
Study Type Descriptive cross-sectional hospital-based study
Population Adults aged 18 years and older receiving inpatient treatment for substance use disorders at Mathari National Teaching and Referral Hospital in Nairobi, Kenya
Exposure or Intervention Self-reported adverse childhood experiences measured with the WHO Adverse Childhood Experiences International Questionnaire (ACE-IQ)
Comparator Participants with versus without specific ACE categories, with regression models adjusted for selected demographic and family-history variables
Primary Outcomes Prevalence of ACEs and associations between ACE categories and lifetime or current use of alcohol, tobacco, cannabis, khat, sedatives, and other substances using ASSIST
Sample Size or Scope 134 participants; 88.1% male; data collection over 2 months
Journal BMC Psychiatry
Year 2018
DOI 10.1186/s12888-018-1780-1
Funding or Conflicts The authors declared no competing interests. A specific funding statement was not clearly identified in the parsed text provided.
Clinical Bottom Line

This study does not prove that childhood adversity causes later addiction, but it strongly supports trauma-aware assessment in substance use treatment settings. Clinicians should read it as a signal to ask better questions, not as a basis for deterministic conclusions.

What This Paper Looked At

The investigators recruited 134 adults receiving inpatient treatment for substance use disorders at Kenya’s national referral psychiatric hospital. After excluding people with active psychopathology severe enough to interfere with participation, they collected demographic information, ACE exposure histories, and substance-use data using standardized questionnaires. The study then examined how individual ACE categories, and total ACE burden, related to lifetime and current use of several commonly used substances. In practical terms, this paper looked at whether adverse childhood experiences and substance use disorders clustered together in this treatment population, and whether some childhood stressors appeared more strongly associated with particular substances than others.

What the Paper Found

ACE exposure was very common. Overall, 92.5% of participants reported at least one ACE, and many reported multiple adversities. The most frequently reported ACE was having one or no parent, reported by 50.0%, followed closely by household member treated violently at 49.3%. The most commonly used current substances were alcohol at 82.1%, tobacco at 74.6%, cannabis at 56.7%, and khat at 46.3%. In adjusted models, emotional abuse was associated with current tobacco use and current sedative use; physical abuse was associated with current cannabis use; having someone with mental illness in the household was associated with current tobacco use; and physical neglect was associated with current sedative use. The authors also reported that experiencing five or more ACEs was associated with increased risk of sedative use.

How Strong Is This Evidence?

This is lower-to-moderate strength observational evidence for association, useful for hypothesis generation and clinical awareness but not for causal inference. It gains some credibility from using recognized screening tools and adjusted regression models, yet it remains limited by its cross-sectional structure, single-site design, and relatively small sample. In the evidence hierarchy, it sits well below longitudinal cohorts, well-designed comparative studies, and any intervention research that could test whether trauma screening or trauma treatment changes substance-use outcomes.

Where This Paper Deserves Skepticism

First, this was a convenience sample of 134 inpatients from one referral psychiatric hospital, so generalizability is limited. Second, both ACE exposure and substance history relied on retrospective self-report, which introduces recall bias and possible under-reporting or over-reporting. Third, the study is cross-sectional, so although the childhood adversity logically preceded adulthood treatment status, the design still cannot sort out all the pathways linking adversity, psychiatric symptoms, resilience, family structure, poverty, or access to care. Fourth, several odds ratios are wide, which usually means the estimates are imprecise. Fifth, the sample was overwhelmingly male, so the findings should not be treated as equally representative of women in treatment. Finally, some seemingly protective findings, especially around khat, should be interpreted very cautiously because they may reflect unmeasured confounding, cultural context, statistical instability, or the specific makeup of this hospitalized sample rather than a true protective effect.

What This Paper Does Not Show

It does not show that a specific adverse childhood experience caused a specific substance use disorder. It does not show that screening for ACEs automatically improves treatment outcomes. It does not show that these exact patterns apply to community samples, outpatient samples, adolescents, or non-Kenyan populations. It also does not prove that the observed associations are biologically direct rather than mediated through depression, anxiety, PTSD, social disadvantage, or other psychiatric and environmental variables.

How This Fits With the Broader Clinical Conversation
This study fits with a large broader literature showing that childhood abuse, neglect, household dysfunction, and violence often travel with later psychiatric burden and substance problems. What it adds is setting-specific data from a Kenyan referral hospital, which is valuable because trauma and addiction research is still disproportionately concentrated in high-income countries. It also reinforces a clinically important idea: adverse childhood experiences and substance use disorders belong in the same assessment frame, even when the exact mechanisms remain uncertain. Thoughtful clinicians should therefore see trauma history as part of the diagnostic landscape, while resisting the temptation to reduce every addiction story to a single childhood explanation.
Dr. Caplan’s Take
One of the easiest ways to misunderstand papers like this is to turn them into moral storytelling. That would be a mistake. The more careful reading is that a heavy trauma burden is common in addiction treatment settings, and that clinicians who ignore developmental history may be missing part of the patient’s real medical context.
At the same time, we should not overread this as destiny. A cross-sectional study cannot tell us which adversities mattered most, which pathways were buffered by resilience, or how many patients might have followed different courses with different social supports. Good medicine here means humility, better screening, and more individualized care.
What a Careful Reader Should Take Away

This paper gives a useful, sober signal that childhood adversity is very common among adults receiving inpatient treatment for substance use disorders in this setting, and that certain ACE categories were associated with specific current substance patterns. The right takeaway is not that trauma explains everything. The right takeaway is that trauma history probably deserves routine clinical attention, while interpretation remains bounded by the limits of retrospective, cross-sectional, single-site data.

? Join the Conversation

Questions about trauma-informed substance use care? Ask Dr. Caplan →

Want to discuss how evidence like this should shape clinical care? Join the forum discussion →

Have thoughts on this? Share it:

? Share on X
in Share on LinkedIn
? Share on BlueSky
? Follow on Instagram
? Read more on Substack
? Subscribe via RSS
? Source:
Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya

Frequently Asked Questions

1. What kind of study was this?

It was a descriptive cross-sectional study of adults receiving inpatient treatment for substance use disorders at a psychiatric referral hospital in Kenya.

2. Did the study prove that childhood trauma causes addiction?

No. It showed associations between self-reported childhood adversity and substance-use patterns, but the design cannot prove causation.

3. How common were adverse childhood experiences in this sample?

Very common. About 92.5% of participants reported at least one ACE, and many reported multiple ACE categories.

4. Which substances were most commonly used?

Current use was highest for alcohol, followed by tobacco, cannabis, and khat.

5. Which childhood adversities were linked to current substance use?

The clearest reported associations were emotional abuse with tobacco and sedative use, physical abuse with cannabis use, and household mental illness with tobacco use.

6. Why should clinicians care about this paper?

Because it supports trauma-informed assessment in addiction care and reminds clinicians that substance-use presentations often sit inside a broader developmental and family history.

7. Can these results be generalized to everyone with addiction?

Not confidently. This was a single-site inpatient sample recruited by convenience sampling, and the findings may not apply to community or outpatient populations.

8. Were there any important limitations beyond sample size?

Yes. The data were retrospective self-report, the confidence intervals were wide for some associations, and several potentially important modifiers such as resilience and comorbid psychiatric illness were not measured.

9. Does this paper support routine ACE screening in substance treatment settings?

It supports the idea that trauma history is clinically relevant, but it does not by itself prove that screening alone improves outcomes. Screening is most meaningful when paired with thoughtful, trauma-informed care pathways.

10. What is the most careful one-sentence takeaway?

Childhood adversity was extremely common in this inpatient addiction sample and was associated with several current substance-use patterns, but the study cannot tell us how much of that relationship is causal.

{“@context”:”https://schema.org”,”@type”:”Article”,”headline”:”Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Actually Shows”,”about”:”adverse childhood experiences and substance use disorders”,”url”:”https://cedclinic.com/adverse-childhood-experiences-and-substance-use-disorders-kenya-study/”,”description”:”Adverse childhood experiences and substance use disorders are closely linked in this Kenyan hospital study, which found very high ACE exposure among inpatients receiving treatment and identified several trauma-related factors associated with current tobacco, cannabis, and sedative use.”}

CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

Leave a Message
Metabolic Care
Medical Consulting
Cannabis Care


Dr. Benjamin Caplan

RELATED READING AT CED CLINIC
Continue exploring the evidence

Endocannabinoid System Research: Cannabis, PTSD & SUD Care

Explore how the endocannabinoid system relates to PTSD and substance use disorder care, highlighting trauma-informed approaches.


Learn More


Cannabinoid Clinical Trials: Mental Health & Substance Use

Review recent clinical trials on cannabinoids focusing on mental health and substance use disorder treatments.


Read the Review


Cannabis Use Disorder Treatment Europe Review

A comprehensive review of cannabis use disorder treatments in Europe, emphasizing evidence-based care.


Explore the Review

  • Newsletter Signup Form

    Enter your email address to subscribe to our newsletter.
  • Should be Empty:

Read next

Nabiximols vs. Cannabis Decoction for MS Spasticity: What a New Formulation Comparison Study Found

Related

Tags:

alcohol use disorderBehavioral HealthCannabis UsePublic healthSubstance use disorders
Author

Benjamin Caplan, MD

Follow Me
Other Articles
Editorial image for Can a psychedelic journey change what you value most? - PsyPost
Previous

Can a Psychedelic Journey Change What You Value Most? – PsyPost

Editorial image for Scientists create “smart” DNA drug that targets cancer cells with extreme precision | ScienceDaily
Next

Scientists Create “Smart” DNA Drug Targeting Cancer Cells with Extreme Precision

Book Now Intake Form
Dr. Benjamin Caplan, MD Learn About Dr. Caplan
Copyright 2026 — CED Clinic. All rights reserved.

Questions about this research?

Talk to Dr. Caplan →
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU